Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No price history available for this symbol yet.
No one on the platform currently holds MBX.TO.
No tracked institution reports a position in MBX.TO as of their last filing.
No one on the platform has traded MBX.TO yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $18M | -0.5% | $-0.01 | $-0.01–$-0.01 | — | 1 |
| 2027 | $21M | +12.0% | $0.01 | $0.01–$0.01 | — | 1 |
| 2028 | $25M | +20.0% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| +3.80% |
| $65M |
| — |
| DOSE.CNRapid Dose Therapeutics Corp. | $0.11 | +4.76% | $15M | — |
| DTC.CNDefence Therapeutics Inc. | $0.41 | +3.85% | $31M | — |
Source: Financial Modeling Prep · peers by sector/industry